Article
Prioritization of pathogenic mutations in the protein kinase superfamily.
BMC genomics - 18 Jun 2012
Izarzugaza Jose M G, del Pozo Angela, Vazquez Miguel, Valencia Alfonso
Abstract excerpt
BACKGROUND: Most of the many mutations described in human protein kinases are tolerated without significant disruption of the corresponding structures or molecular functions, while some of them have been associated to a variety of human diseases, including cancer. In the last decade, a plethora of computational methods to predict the effect of missense single-nucleotide variants (SNVs) have been developed. Still,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
